Diagnosis of latent tuberculosis infection in bacille Calmette- Guérin vaccinated subjects in China by interferon-gamma ELISpot assay

International Journal of Tuberculosis and Lung Disease

Volumn 14, Issue 12, 2010, Pages 1556-1563

  Zhang, M ^a   Wang, H ^a   Liao, M ^b   Chen, X ^a,b,c   Graner, M ^d   Zhu, X ^a   Zhang, J ^a   Yang, Q ^a   Lu, H ^a   Zhou, B ^a  

^a SHENZHEN THIRD PEOPLE S HOSPITAL   (China)

^b GUANGDONG MEDICAL UNIVERSITY   (China)

^c SHENZHEN POLYTECHNIC   (China)

^d UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

Author keywords

BCG vaccination; Interferon gamma release assays; Latent tuberculosis infection

Indexed keywords

BCG VACCINE; GAMMA INTERFERON;

ADULT; ARTICLE; BCG VACCINATION; CD4+ T LYMPHOCYTE; CHINA; CONTROLLED STUDY; CYTOKINE RELEASE; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; ENZYME LINKED IMMUNOSPOT ASSAY; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTERFERON GAMMA RELEASE ASSAY; LATENT TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; MYCOBACTERIUM TUBERCULOSIS; PRIORITY JOURNAL; PROSPECTIVE STUDY; T LYMPHOCYTE; TUBERCULIN TEST;

ADOLESCENT; ADULT; BCG VACCINE; CHINA; ENZYME-LINKED IMMUNOSPOT ASSAY; FEMALE; HIV INFECTIONS; HUMANS; INTERFERON-GAMMA; LATENT TUBERCULOSIS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; YOUNG ADULT;

EID: 78649361347     PISSN: 10273719     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Mack U, Migliori G B, Sester M, et al. LTBI: latent tuberculosis infection or lasting immune responses to M. tuberculosis? A TBNET consensus statement. Eur Respir J 2009; 33: 956-973.
2. Hauck F R, Neese B H, Panchal A S, El-Amin W. Identification and management of latent tuberculosis infection. Am Fam Physician 2009; 79: 879-886.
3. Pai M, Zwerling A, Menzies D. Systematic review: T-cell-based assays for the diagnosis of latent tuberculosis infection: an update. Ann Intern Med 2008; 149: 177-184.
4. Menzies D, Pai M, Comstock G. Meta-analysis: new tests for the diagnosis of latent tuberculosis infection: areas of uncertainty and recommendations for research. Ann Intern Med 2007; 146: 340-354.
5. Lee J Y, Choi H J, Park I N, et al. Comparison of two commercial interferon-gamma assays for diagnosing Mycobacterium tuberculosis infection. Eur Respir J 2006; 28: 24-30.
6. Schablon A, Beckmann G, Harling M, Diel R, Nienhaus A. Prevalence of latent tuberculosis infection among health care workers in a hospital for pulmonary diseases. J Occup Med Toxicol 2009; 4: 1.
7. Mazurek G H, LoBue P A, Daley C L, et al. Comparison of a whole-blood interferon gamma assay with tuberculin skin testing for detecting latent Mycobacterium tuberculosis infection. JAMA 2001; 286: 1740-1747.
8. Diel R, Ernst M, Doscher G, et al. Avoiding the effect of BCG vaccination in detecting Mycobacterium tuberculosis infection with a blood test. Eur Respir J 2006; 28: 16-23.
9. Mantegani P, Piana F, Codecasa L, et al. Comparison of an inhouse and a commercial RD1-based ELISPOT-IFN-gamma assay for the diagnosis of Mycobacterium tuberculosis infection. Clin Med Res 2006; 4: 266-272.
10. Chen X, Yang Q, Zhang M, et al. Diagnosis of active tuberculosis in China using an in-house gamma interferon enzyme-linked immunospot assay. Clin Vaccine Immunol 2009; 16: 879-884.
11. China Tuberculosis Control Collaboration. The effect of tuberculosis control in China. Lancet 2004; 364: 417-422.
12. Jiang W, Shao L, Zhang Y, et al. High-sensitive and rapid d etection of Mycobacterium tuberculosis infection by IFN-gamma release assay among HIV-infected individuals in BCG-vaccinated area. BMC Immunol 2009; 10: 31.
13. Aabye M G, Ravn P, PrayGod G, et al. The impact of HIV infection and CD4 cell count on the performance of an interferon gamma release assay in patients with pulmonary tuberculosis. PLoS ONE 2009; 4: e4220.
14. Leidl L, Mayanja-Kizza H, Sotgiu G, et al. Relationship of immunodiagnostic assays for tuberculosis and numbers of circulating CD4+ T-cells in HIV-infection. Eur Respir J 2010; 35: 619-626.
15. Lawn S D, Bangani N, Vogt M, et al. Utility of interferon-gamma ELISPOT assay responses in highly tuberculosis-exposed patients with advanced HIV infection in South Africa. BMC Infect Dis 2007; 7: 99.
16. Rangaka M X, Wilkinson K A, Seldon R, et al. Effect of HIV-1 infection on T-Cell-based and skin test detection of tuberculosis infection. Am J Respir Crit Care Med 2007; 175: 514-520.
17. Andersen P, Doherty T M, Pai M, Weldingh K. The prognosis of latent tuberculosis: can disease be predicted? Trends Mol Med 2007; 13: 175-182.
18. Dheda K, Lalvani A, Miller R F, et al. Performance of a T-cell-based diagnostic test for tuberculosis infection in HIV-infected individuals is independent of CD4 cell count. AIDS 2005; 19: 2038-2041.
19. Detjen A K, Keil T, Roll S, et al. Interferon-gamma release assays improve the diagnosis of tuberculosis and nontuberculous mycobacterial disease in children in a country with a low incidence of tuberculosis. Clin Infect Dis 2007; 45: 322-328.
20. Johnson P D, Stuart R L, Grayson M L, et al. Tuberculin-purified protein derivative-, MPT-64-, and ESAT-6-stimulated gamma interferon responses in medical students before and after Mycobacterium bovis BCG vaccination and in patients with tuberculosis. Clin Diagn Lab Immunol 1999; 6: 934-937.